Satisfaction with care: an independent outcome measure in surgical oncology

KN Avery, C Metcalfe, J Nicklin, CP Barham, Derek Alderson, JL Donovan, JM Blazeby

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

BACKGROUND: Outcomes for treatment for upper gastrointestinal cancer traditionally include procedure-related morbidity and mortality and long-term survival. Patient-reported outcomes, such as quality of life (QOL) and satisfaction measures, add to standard end points, but associations between these factors are not fully understood. This study examined how patient satisfaction related to surgical morbidity, treatment type, and QOL outcomes after inpatient treatment for upper gastrointestinal cancer. METHODS: Consecutive patients who had completed treatment in one unit were invited to participate in this study and complete the European Organization for Research and Treatment of Cancer QLQ-PATSAT32 and QLQ-C30 questionnaires within 2 months of discharge. Regression analyses examined relationships between satisfaction and surgical morbidity (major complications and type of treatment) and between satisfaction and QOL variables, adjusting for age and sex. RESULTS: During the study, 181 patients were treated, 162 were eligible, and 139 returned both questionnaires (response rate, 86%). Of the study sample, the treatment outcome was potential cure in 105 (67 esophagectomy and 38 D2 gastrectomy), and 34 received palliative treatment. Thirty-seven patients (27%) had major complications. Patients who received palliative treatment reported satisfaction and QOL scores similar to those of patients who received curative treatment. However, patients who experienced major morbidity reported significantly worse QOL than those without morbidity (P
Original languageEnglish
Pages (from-to)817-822
Number of pages6
JournalAnnals of Surgical Oncology
Volume13
Issue number6
DOIs
Publication statusPublished - 1 Jun 2006

Fingerprint

Dive into the research topics of 'Satisfaction with care: an independent outcome measure in surgical oncology'. Together they form a unique fingerprint.

Cite this